Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Week in Review: Life at a heart hospital in Ukraine | Pregnant cardiologists mistreated | Telecardiology during the pandemic
Saturday, March 19, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

Pfizer finalizes $6.7 billion acquisition of Arena Pharmaceuticals, gaining key cardiovascular treatments

Etrasimod, an oral medication developed to treat certain inflammatory conditions, was at the center of Pfizer’s acquisition, but some key cardiovascular assets were also part of the transaction. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Pfizer finalizes $6.7 billion acquisition of Arena Pharmaceuticals, gaining key cardiovascular treatments

Share on Twitter Share on Facebook Share on Linkedin
Etrasimod, an oral medication developed to treat certain inflammatory conditions, was at the center of Pfizer’s acquisition, but some key cardiovascular assets were also part of the transaction. 
READ MORE >

Heart hospital in Ukraine treating wounded civilians

Cardiothoracic surgeon Igor Mokryk, MD, spent last week taking his family to the Polish border. This week, he treated his first gunshot wound patient at the Heart Institute in Kyiv.

READ MORE >
A CT image from the Heart Institute in Kyiv, Ukraine, showing a Russian bullet in a civilian patient's upper lung lobe. The patient was being treated at the cardiology hospital after he tried to drive his family out of the area of the front lines and was shot at by Russian soldiers. He is being treated by cardiac surgeon Igor Mokryk MD. Photo by Igor Mokryk.
Share on Twitter Share on Facebook Share on Linkedin

Heart hospital in Ukraine treating wounded civilians

Share on Twitter Share on Facebook Share on Linkedin
A CT image from the Heart Institute in Kyiv, Ukraine, showing a Russian bullet in a civilian patient's upper lung lobe. The patient was being treated at the cardiology hospital after he tried to drive his family out of the area of the front lines and was shot at by Russian soldiers. He is being treated by cardiac surgeon Igor Mokryk MD. Photo by Igor Mokryk.
Cardiothoracic surgeon Igor Mokryk, MD, spent last week taking his family to the Polish border. This week, he treated his first gunshot wound patient at the Heart Institute in Kyiv.
READ MORE >

Pregnant cardiologists are consistently mistreated by employers: 8 key takeaways from a new analysis

A significant number of cardiologists are mistreated—often in more ways than one—after they tell their employer they are pregnant. 

READ MORE >
women doctors
Share on Twitter Share on Facebook Share on Linkedin

Pregnant cardiologists are consistently mistreated by employers: 8 key takeaways from a new analysis

Share on Twitter Share on Facebook Share on Linkedin
women doctors
A significant number of cardiologists are mistreated—often in more ways than one—after they tell their employer they are pregnant. 
READ MORE >

Telehealth provided value for heart failure patients during COVID-19 pandemic

Overall, researchers found, 30-day readmission was less common when heart failure patients used telehealth to check in with a physician after discharge. 

READ MORE >
A patient has a telehealth visit with their doctor remotely in their home via video conferencing. The COVID-19 cause massive movement to telehealth since 2020.
Share on Twitter Share on Facebook Share on Linkedin

Telehealth provided value for heart failure patients during COVID-19 pandemic

Share on Twitter Share on Facebook Share on Linkedin
A patient has a telehealth visit with their doctor remotely in their home via video conferencing. The COVID-19 cause massive movement to telehealth since 2020.
Overall, researchers found, 30-day readmission was less common when heart failure patients used telehealth to check in with a physician after discharge. 
READ MORE >

AFib, AI and heart-healthy diets: European Society of Cardiology previews EHRA 2022

The European Heart Rhythm Association's annual conference is headed to Denmark. 

READ MORE >
EHRA 2022, the yearly get-together hosted by the European Heart Rhythm Association (EHRA), is scheduled for April 3-5 at the Bella Center in Copenhagen, Denmark. European Society of Cardiology
Share on Twitter Share on Facebook Share on Linkedin

AFib, AI and heart-healthy diets: European Society of Cardiology previews EHRA 2022

Share on Twitter Share on Facebook Share on Linkedin
EHRA 2022, the yearly get-together hosted by the European Heart Rhythm Association (EHRA), is scheduled for April 3-5 at the Bella Center in Copenhagen, Denmark. European Society of Cardiology
The European Heart Rhythm Association's annual conference is headed to Denmark. 
READ MORE >

COVID-19 vaccines safe for patients with a history of heart damage

“These results provide reassuring data that may encourage patients with a history of myocarditis to get vaccinated against SARS-CoV-2,” one specialist said. 

READ MORE >
There has been fear of a small number of patients who experience myocarditis after COVID vaccination, but a new study found it is safe in patients with prior heart damage. Image courtesy of Banner Health. #COVID19 #COVIDvaccination
Share on Twitter Share on Facebook Share on Linkedin

COVID-19 vaccines safe for patients with a history of heart damage

Share on Twitter Share on Facebook Share on Linkedin
There has been fear of a small number of patients who experience myocarditis after COVID vaccination, but a new study found it is safe in patients with prior heart damage. Image courtesy of Banner Health. #COVID19 #COVIDvaccination
“These results provide reassuring data that may encourage patients with a history of myocarditis to get vaccinated against SARS-CoV-2,” one specialist said. 
READ MORE >

ACC consensus explains what cardiologists should look for in long COVID-19

The new consensus document provides a framework for understanding, evaluating, and managing some of the key cardiovascular sequelae of COVID-19

READ MORE >
covid_myocarditis_rsna_cdc_images.jpg
Share on Twitter Share on Facebook Share on Linkedin

ACC consensus explains what cardiologists should look for in long COVID-19

Share on Twitter Share on Facebook Share on Linkedin
covid_myocarditis_rsna_cdc_images.jpg
The new consensus document provides a framework for understanding, evaluating, and managing some of the key cardiovascular sequelae of COVID-19
READ MORE >

War in Ukraine has not stopped congenital heart surgeries in Kyiv

"We are staying strong," one surgeon told Cardiovascular Business. 

READ MORE >
 Oleksandr Yachnik, congenital heart surgeon at the Scientific Practical Children's Cardiac Center in Kyiv, Ukraine, performs a congential heart procedure while the Russians and the front lines are less than 10 miles away. #StandwithUkraine #Ukraine #RussianWarWithUkraine
Share on Twitter Share on Facebook Share on Linkedin

War in Ukraine has not stopped congenital heart surgeries in Kyiv

Share on Twitter Share on Facebook Share on Linkedin
 Oleksandr Yachnik, congenital heart surgeon at the Scientific Practical Children's Cardiac Center in Kyiv, Ukraine, performs a congential heart procedure while the Russians and the front lines are less than 10 miles away. #StandwithUkraine #Ukraine #RussianWarWithUkraine
"We are staying strong," one surgeon told Cardiovascular Business. 
READ MORE >

Telecardiology during the COVID-19 pandemic showed cardiologists another way to treat patients

Telecardiology saw a major boost during the COVID-19 pandemic. Many health systems now want to keep it as a permanent treatment option. 

READ MORE >
Telecardiology saw a major boost during the COVID-19 pandemic. Many health systems now want to keep it as a permanent treatment option.
Share on Twitter Share on Facebook Share on Linkedin

Telecardiology during the COVID-19 pandemic showed cardiologists another way to treat patients

Share on Twitter Share on Facebook Share on Linkedin
Telecardiology saw a major boost during the COVID-19 pandemic. Many health systems now want to keep it as a permanent treatment option.
Telecardiology saw a major boost during the COVID-19 pandemic. Many health systems now want to keep it as a permanent treatment option. 
READ MORE >

Cancer, cancer-related death much more common among heart failure patients

Researchers examined data from more than 208,000 patients, sharing their findings in JACC: CardioOncology. 

READ MORE >
lung cancer pulmonary nodule
Share on Twitter Share on Facebook Share on Linkedin

Cancer, cancer-related death much more common among heart failure patients

Share on Twitter Share on Facebook Share on Linkedin
lung cancer pulmonary nodule
Researchers examined data from more than 208,000 patients, sharing their findings in JACC: CardioOncology. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme